DALFAMPRIDINE

Generic: DALFAMPRIDINE

Ascend LaboratoriesManufacturer
ORALRoute
DALFAMPRIDINEActive Substance
2018-07-30Original Approval

DALFAMPRIDINE is FDA application ANDA206765, sponsored by ALKEM LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
FALL
1,077 reports
2
GAIT DISTURBANCE
1,016 reports
3
DRUG INEFFECTIVE
841 reports
4
FATIGUE
826 reports
5
COVID-19
586 reports
6
MULTIPLE SCLEROSIS RELAPSE
586 reports
7
BALANCE DISORDER
555 reports
8
MULTIPLE SCLEROSIS
521 reports
9
ASTHENIA
445 reports
10
DIZZINESS
416 reports